Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.465
+0.095 (6.93%)
Jun 26, 2026, 2:18 PM EDT - Market open
Ocugen Market Cap
Ocugen has a market cap or net worth of $495.93 million as of June 26, 2026. Its market cap has increased by 46.40% in one year.
Market Cap
495.93M
Enterprise Value
500.76M
1-Year Change
46.40%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $495.93M, an increase of 1,414.33%. That is a compound annual growth rate of 49.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 495.93M | 17.62% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cabaletta Bio | 492.43M |
| Neurogene | 487.65M |
| Sutro Biopharma | 483.69M |
| Artiva Biotherapeutics | 476.16M |
| C4 Therapeutics | 466.59M |
| Nuvectis Pharma | 465.52M |
| Contineum Therapeutics | 445.27M |
| Forte Biosciences | 443.51M |